Canada issues warning over glucose monitors:
This article was originally published in Clinica
Patients with kidney failure who use Baxter's peritoneal dialysis solution containing icodextrin (Extraneal) should ensure that they use glucose monitors not subject to interference from sugars that are released by the icodextrin. The result of using the wrong type of monitor is a falsely elevated glucose monitor reading, which can also mask a consequent hypoglycaemic effect, which could result in coma if, due to being masked, it is left untreated. Health Canada has advised patients who use icodextrin-containing dialysis solution to wear some form of personal identification, such as the bracelets and pendants available from MedicAlert, to help avoid the danger.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.